Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales.